184 related articles for article (PubMed ID: 11759254)
1. [Experience with montelukast, a leukotriene receptor antagonist, in pediatric patients with asthma].
Vega López M; Jiménez Ferral R
Rev Alerg Mex; 2001; 48(5):133-6. PubMed ID: 11759254
[TBL] [Abstract][Full Text] [Related]
2. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
3. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
4. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
Gaszczyk G; Latoś T; Słowikowski A; Janiak B
Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
[TBL] [Abstract][Full Text] [Related]
5. [Importance of leukotriene antagonists in asthma therapy raised].
MMW Fortschr Med; 2008 Mar; 150(13):44-5. PubMed ID: 18522358
[No Abstract] [Full Text] [Related]
6. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
Currie GP; Lee DK; Menzies D; Lipworth BJ
Chest; 2006 Jul; 130(1):301-2. PubMed ID: 16840420
[No Abstract] [Full Text] [Related]
7. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of montelukast in the treatment of cough variant asthma.
Spector SL; Tan RA
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381
[TBL] [Abstract][Full Text] [Related]
9. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
[TBL] [Abstract][Full Text] [Related]
10. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.
Bisgaard H; Zielen S; Garcia-Garcia ML; Johnston SL; Gilles L; Menten J; Tozzi CA; Polos P
Am J Respir Crit Care Med; 2005 Feb; 171(4):315-22. PubMed ID: 15542792
[TBL] [Abstract][Full Text] [Related]
11. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
12. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.
Barnes N; Wei LX; Reiss TF; Leff JA; Shingo S; Yu C; Edelman JM
Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579
[TBL] [Abstract][Full Text] [Related]
13. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM
Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
[TBL] [Abstract][Full Text] [Related]
14. Montelukast in childhood asthma: what is the evidence for its use?
Amlani S; McIvor RA
Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582
[TBL] [Abstract][Full Text] [Related]
15. Effects of montelukast in patients with persistent asthma using inhaled corticosteroids plus additional second-line therapy.
Currie GP; Anderson WJ; Lee DK
J Allergy Clin Immunol; 2005 Jul; 116(1):230. PubMed ID: 15990804
[No Abstract] [Full Text] [Related]
16. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
Raissy HH; Harkins M; Kelly F; Kelly HW
Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
[TBL] [Abstract][Full Text] [Related]
17. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients.
Virchow JC; Mehta A; Ljungblad L; Mitfessel H
J Asthma; 2010 Nov; 47(9):986-93. PubMed ID: 20858152
[TBL] [Abstract][Full Text] [Related]
18. Marginal utility of montelukast for persistent asthma.
Mathison DA; Koziol JA
Chest; 2002 Feb; 121(2):334-7. PubMed ID: 11834640
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
20. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.
Simons FE; Villa JR; Lee BW; Teper AM; Lyttle B; Aristizabal G; Laessig W; Schuster A; Perez-Frias J; Sekerel BE; Menten J; Leff JA
J Pediatr; 2001 May; 138(5):694-8. PubMed ID: 11343045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
